Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on September 13th, 2023%
A new award from National Institutes of Health funds preclinical work to prepare for a clinical trial assessing a treatment to reverse brain signaling damage in people with Alzheimer’s disease. . . . → Read More: Small Biz Grant Supports Regenerative Alzheimer’s Treatment
By Alan, on September 6th, 2023%
A company formed by M.D. Anderson Cancer Center and Panacea Venture plans to develop synthetic antibodies as treatments addressing new cancer targets. . . . → Read More: Venture Firm, Cancer Center Start Antibody Biotech Company
By Alan, on August 23rd, 2023%
The Department of Health and Human Services is allocating $100 million for venture investments in new technologies to prepare for future threats from Covid-19. . . . → Read More: HHS Directs $100M for Covid-19 Venture Investments
By Alan, on August 2nd, 2023%
A company, spun-off from academic labs that designs and produces new chemicals with artificial intelligence and robotics, is raising $42.7 million in its first venture funding round. . . . → Read More: Digital Chemistry Start-Up Gains $43M in Early Funds
By Alan, on August 1st, 2023%
The developer of a biologic drug-making process with engineered plant crops is collaborating with a vertical farming company to create a network of biologics production facilities. . . . → Read More: Companies Partner on Fast Production of Biologics in Plants
By Alan, on July 19th, 2023%
A synthetic biology company is receiving a contract with the U.S. advanced defense research agency to devise a high-speed localized process for making therapeutic proteins. . . . → Read More: Darpa Seeking On-Demand, Distributed Production of Proteins
By Alan, on June 15th, 2023%
A synthetic biology company says it can now produce engineered cells from stem cells for research to precise specifications, and in large quantities and consistent quality. . . . → Read More: Synthetic Bio Company Manufactures Research Cells
By Alan, on June 8th, 2023%
A biological testing device company and industrial graphene manufacturer are collaborating on large-scale production of graphene biosensors for widespread use. . . . → Read More: Partnership to Mass-Produce Graphene Biosensors
By Alan, on May 26th, 2023%
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma
By Alan, on May 23rd, 2023%
A venture investment fund and university bioengineering center are creating a laboratory to design more sustainable alternative materials to help address the climate crisis. . . . → Read More: Lab to Develop New Bio-Based Sustainable Materials
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|